R. Mark Adams, Chief Operating Officer at Adaptive Biotechnologies Corp (ADPT), sold 17,828 shares at $38.77 ($691K) on 2021-06-14, disclosed to the SEC on 2021-06-16.
Open-market sale of $691k ADPT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.77 | 8,914 | $346K | 50.0% |
| 2 | $38.77 | 8,914 | $346K | 50.0% |
| Total | $38.77 avg | 17,828 | $691K | 100% |
| Filing → |
| ADPT | SELL | 2023-01-11 | $27K | — | Filing → |
| ADPT | SELL | 2022-10-11 | $23K | — | Filing → |
| ADPT | SELL | 2022-07-08 | $32K | — | Filing → |